Author:
Rubenstein Marvin,Hollowell Courtney M. P.,Guinan Patrick
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology,General Medicine
Reference19 articles.
1. Rubenstein M, Hollowell CMP, Guinan P. Inhibition of bcl-2 by antisense oligonucleotides is followed by a compensatory suppression of caspase-3 in LNCaP cells. Eur J Clin and Med Oncol. 2011;3:1–6.
2. Mu Z, Hachem P, Pollack A. Antisense bcl-2 sensitizes prostate cancer cells to radiation. Prostate. 2005;65:331–40.
3. Yip KW, Mocanu JD, Au PY, Sleep GT, Busson D, Yeh P, Gilbert WC, O’Sullivan R, Gullane B, Bastianutto C, Liu FF. Combination bcl-2 antisense and radiation therapy for nasopharyngeal cancer. Clin Cancer Res. 2005;11:8131–44.
4. Yamanaka K, Miyake H, Zangemeister-wittke U, Jansen B, Gleave M. Novel bispecific antisense oligonucleotides inhibiting both bcl-2 and Bcl-xL expression induce apoptosis and enhance chemosensitivity in human androgen-independent prostate cancer cells. Proceedings AACR 45: (online) abstract #2930, 2004.
5. Rubenstein M, Hollowell CMP, Guinan P. In LNCaP cells enhanced expression of the androgen receptor compensates for bcl-2 suppression by antisense oligonucleotides. Ther Adv Urol. 2011;3:73–9.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献